Robert B Ford insider trades
Open-market stock purchases and sales by Robert B Ford, CHAIRMAN AND CEO at Abbott Laboratories, from SEC Form 4 filings since Jul 1, 2014.
Track record: 83% of 6 scored buys are up 5% or more since purchase, averaging +132%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 25, 2026 | ABT Abbott Laboratories | Sold | $25.3M |
| Aug 25, 2026 | ABT Abbott Laboratories | Sold | $20.9M |
| Aug 25, 2026 | ABT Abbott Laboratories | Bought (not open market) | — |
| Aug 25, 2026 | ABT Abbott Laboratories | Bought (not open market) | — |
| Feb 27, 2026 | ABT Abbott Laboratories | Sold (not open market) | $3.5M |
| Feb 24, 2026 | ABT Abbott Laboratories | Bought (not open market) | — |
| Feb 24, 2026 | ABT Abbott Laboratories | Bought (not open market) | — |
| Jan 23, 2026 | ABT Abbott Laboratories | Bought | $2M |
Companies traded
- ABT Abbott Laboratories: 6 buys, 34 sales, last Aug 25, 2026